SCHEMBL1662269

SCHEMBL1662269

NC(c1cccc(F)c1)C1(C(=O)O)CC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC4 P56524 1/20 0.44
HDAC7 Q8WUI4 1/20 0.44
HDAC5 Q9UQL6 1/20 0.44
CES2 O00748 1/20 0.43
CES1 P23141 1/20 0.43
EPHX1 P07099 1/20 0.41
IDO1 P14902 1/20 0.41
TDO2 P48775 1/20 0.41
CNR2 P34972 1/20 0.40
USP2 O75604 2/20 0.40
CYP3A4 P08684 2/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40
TSHR P16473 1/20 0.40
MTOR P42345 1/20 0.40
KDM4E B2RXH2 1/20 0.40
SLC1A1 P43005 2/20 0.39
ALDH1A1 P00352 1/20 0.39
OPRM1 P35372 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL515696 0.74 SLC6A2 (0.46) CYP2D6ALDH1A1OPRM1OPRD1OPRL1
SCHEMBL9486483 0.73 AKR1C1 (0.43) HDAC4CYP2D6
SCHEMBL2597751 0.73 HDAC4 (0.51) HDAC4HDAC7HDAC5CES2CES1
SCHEMBL431704 0.73 HDAC4 (0.51) HDAC4HDAC7HDAC5CES2CES1
SCHEMBL29440623 0.73 HDAC4 (0.51) HDAC4HDAC7HDAC5CES2CES1
SCHEMBL23904583 0.73 HDAC4 (0.51) HDAC4HDAC7HDAC5CES2CES1
SCHEMBL15601047 0.70 CYP2C9 (0.42) HDAC4HDAC7HDAC5CYP3A4CYP1A2
SCHEMBL19696914 0.70 SLC1A1 (0.54) HDAC4HDAC7HDAC5CES2CES1
SCHEMBL2311787 0.70 SLC1A1 (0.54) HDAC4HDAC7HDAC5CES2CES1
SCHEMBL5523612 0.70 EPHX1 (0.49) HDAC4HDAC7HDAC5CES2CES1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-2011524906-A 2011-09-08 JP claimed
EP-2306994-A1 S1P1 RECEPTOR AGONISTS AND USE THEREOF Amgen, Inc (US) 2011-04-13 EP claimed
WO-2009154775-A1 S1P1 RECEPTOR AGONISTS AND USE THEREOF AMGEN INC. (US) 2009-12-23 WO claimed